CP-340868

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameCP-340868
Drug Alias NameCP-340868
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSqualene synthase inhibitors
TargetsSqualene synthase
Therapy Area/IndicationsHypercholesterolemiaAtherosclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPfizer Inc
Active IndicationsN/A
Inactive IndicationsHypercholesterolemiaAtherosclerosis

Other Information

ATC CodeN/A
Related LinksN/A